CMF9 Thyroid Cancer: Advanced Cases

Program: Case Management Forums
Clinical Session
Sunday, April 3, 2016: 3:30 PM-4:15 PM
Room 258 (BCEC)
Mona M. Sabra, MD, Memorial Sloan Kettering Cancer Center, New York, NY and Bryan R. Haugen, MD, University of Colorado Medical School, Aurora, CO

BRH: Investigator, Genzyme Corporation, Speaker, Genzyme Corporation. Nothing to Disclose: MMS
See more of: Case Management Forums


The Endocrine Society would like to thank the following organizations for their support: AbbVie Inc.; Bayer HealthCare Pharmaceuticals Inc.; Boehringer Ingelheim Pharmaceuticals, Inc.; Chiasma, Inc.; Corcept Therapeutics Incorporated; Eisai, Inc.; Ethicon Endo-Surgery, Inc.; Genzyme, a Sanofi company, Ipsen Biopharmaceuticals, Inc.; Leona M. and Harry B. Helmsley Charitable Trust; Lilly USA, LLC; Medtronic Diabetes; Merck & Co., Inc.; Novartis Pharmaceuticals Corporation; Novo Nordisk Inc.; Pfizer, Inc.; Shire